ChromoTek’s fluorescent two hybrid (F2H®) technology enables screening and validation of compounds in living cells
more
Push For Smart Industry: ChromoTek wins category "Biotechnology" and the overall first prize from 1200 participating companies.
moreVisit us at the annual meeting of the American Association for Cancer Research, booth 1038!
moreChromoTek's Chromobody® Technology for High Content drug profiling licensed to Bayer
moreBinding controls
When you do your pulldown with our Nano-Traps (GFP-Trap®/ RFP-Trap®), some proteins probably bind unspecifically to the agarose beads or the magnetic particles. Therefore we provide identically treated beads/ particles without coupled Nano-Traps as control for unspecifically bound proteins.
You can use these Blocked agarose beads and Blocked magnetic particles also for a pre-clearing step to deplete unspecifically binding proteins prior to the pulldown.



